{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "P",
                    "position": "42"
                },
                "variant_string_id": "PARK2 R42P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Autosomal recessive juvenile Parkinsonism (ARJP) is an early onset familial form of Parkinson's disease. Mutations in the E3 ubiquitin - protein ligase parkin (encoded by PARK2 gene) account for approximately 50% of all ARJP cases. The ubiquitination pathway, in which parkin is an essential enzyme, signals or regulates protein degradation via the 26S proteasome and non - proteolytic processes.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines ARJP as a form of Parkinson's disease and explains the role of parkin in the ubiquitination pathway related to the disease.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Urea unfolding experiments, thermal denaturation, circular dichroism spectropolarimetry, NMR spectroscopy, and size exclusion chromatography were used. These assays are relevant as they can assess protein folding, stability, and structure, which are related to the function of parkin in the ubiquitination pathway.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the impact of mutations on the structure and function of parkin, which is related to the disease pathogenesis. For example, urea unfolding and CD can show changes in protein stability, NMR can show structural changes, and size exclusion can show protein aggregation or folding states.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "All unfolding experiments were conducted in duplicate. Protein samples for unfolding experiments included wild - type proteins (parkin Ubld and ubiquitin) as normal controls. No information on abnormal/positive/null controls was found.",
                    "judgment": "No",
                    "reasoning": "Although the experiments were done in duplicate and had wild - type proteins as controls, there is no evidence of abnormal/positive/null controls. So, we proceed to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Urea unfolding, CD spectropolarimetry, NMR spectroscopy, and size exclusion chromatography are standard techniques in protein structure and stability studies. Circular dichroism has been used previously in many protein folding studies. NMR spectroscopy is a well - established method for determining protein structures. Size exclusion chromatography is a common technique for analyzing protein size and aggregation states.",
                    "judgment": "Yes",
                    "reasoning": "The specific instances of the assays used are broadly accepted historically in the field of protein research. Thus, the functional evidence strength is Max PS3_supporting.",
                    "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The R42P variant in PARK2 was studied using assays that are standard in the field but lacked proper abnormal/positive/null controls. Since the assays are broadly accepted, the functional evidence strength is PS3_supporting, indicating that the variant likely contributes to the pathogenicity of ARJP by causing the unfolding of the parkin Ubld and disrupting its function in the ubiquitination pathway."
        },
        {
            "variant_id": {
                "Gene": "PARK2",
                "Protein_Change": {
                    "ref": "K",
                    "alt": "A",
                    "position": "48"
                },
                "variant_string_id": "PARK2 K48A"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Autosomal recessive juvenile Parkinsonism (ARJP) is an early onset familial form of Parkinson's disease. Mutations in the E3 ubiquitin - protein ligase parkin (encoded by PARK2 gene) account for approximately 50% of all ARJP cases. The ubiquitination pathway, in which parkin is an essential enzyme, signals or regulates protein degradation via the 26S proteasome and non - proteolytic processes.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines ARJP as a form of Parkinson's disease and explains the role of parkin in the ubiquitination pathway related to the disease.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Urea unfolding experiments, thermal denaturation, circular dichroism spectropolarimetry were used. These assays can assess protein folding and stability, which are relevant to the function of parkin in the ubiquitination pathway.",
                    "judgment": "Yes",
                    "reasoning": "The assays effectively model the impact of mutations on the structure and function of parkin, which is related to the disease pathogenesis. Urea unfolding and CD can show changes in protein stability.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "All unfolding experiments were conducted in duplicate. Protein samples for unfolding experiments included wild - type proteins (parkin Ubld and ubiquitin) as normal controls. No information on abnormal/positive/null controls was found.",
                    "judgment": "No",
                    "reasoning": "Although the experiments were done in duplicate and had wild - type proteins as controls, there is no evidence of abnormal/positive/null controls. So, we proceed to Sub - step 3b.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "Urea unfolding and CD spectropolarimetry are standard techniques in protein structure and stability studies. Circular dichroism has been used previously in many protein folding studies.",
                    "judgment": "Yes",
                    "reasoning": "The specific instances of the assays used are broadly accepted historically in the field of protein research. Thus, the functional evidence strength is Max PS3_supporting.",
                    "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The K48A variant in PARK2 was studied using assays that are standard in the field but lacked proper abnormal/positive/null controls. Since the assays are broadly accepted, the functional evidence strength is PS3_supporting, indicating that the variant likely contributes to the pathogenicity of ARJP, potentially by disrupting the interaction with the S5a proteasome subunit."
        }
    ]
}